Issued Patents All Time
Showing 25 most recent of 45 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12281119 | Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist | Guoliang Zhang, Jianzhuang Miao, Gang Chen, Jing Li | 2025-04-22 |
| 11534431 | Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer | Jing Song, Lai-Xi Wang, Kang Li, Tong Zhang, Lusong Luo +3 more | 2022-12-27 |
| 11472788 | Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases | Hexiang Wang, Yunhang Guo, Zhiwei Wang | 2022-10-18 |
| 11472811 | Pyrazolotriazolopyrimidine derivatives as A2A receptor antagonist | Guoliang Zhang | 2022-10-18 |
| 11202782 | Treatment cancers using a combination comprising PARP inhibitors | Lai-Xi Wang, Zhiyu Tang, Lusong Luo, Min Wei, Kang Li +4 more | 2021-12-21 |
| 10899763 | Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof | Hexiang Wang, Xianzhao Kuang | 2021-01-26 |
| 10882856 | 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases | Hexiang Wang, Yunhang Guo, Bo Ren, Zhiwei Wang, Guoliang Zhang | 2021-01-05 |
| 10864203 | Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer | Jing Song, Lai-Xi Wang, Kang Li, Tong Zhang, Lusong Luo +3 more | 2020-12-15 |
| 10647714 | 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases | Hexiang Wang, Guoliang Zhang, Yunhang Guo, Bo Ren, Zhiwei Wang | 2020-05-12 |
| 10576087 | Fused tricyclic compounds as Raf kinase inhibitors | Shaohui Wang, Guoliang Zhang | 2020-03-03 |
| 10562899 | Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors | Guoliang Zhang | 2020-02-18 |
| 10501467 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Bo Ren, Hexiang Wang | 2019-12-10 |
| 10457680 | Process for preparing a PARP inhibitor, crystalline forms, and uses thereof | Hexiang Wang, Bo Ren, Xianzhao Kuang | 2019-10-29 |
| 10351559 | Maleate salts of a B-RAF kinase inhibitor, crystalline forms, methods of preparation, and uses therefore | Guoliang Zhang | 2019-07-16 |
| 10280163 | 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases | Hexiang Wang, Guoliang Zhang, Yunhang Guo, Bo Ren, Zhiwei Wang | 2019-05-07 |
| 10208038 | Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors | Guoliang Zhang | 2019-02-19 |
| 10112952 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Bo Ren, Hexiang Wang | 2018-10-30 |
| 9920055 | Fused tricyclic urea compounds as raf kinase and/or raf kinase dimer inhibitors | Guoliang Zhang | 2018-03-20 |
| 9895376 | Fused tricyclic compounds as Raf kinase inhibitors | Shaohui Wang, Guoliang Zhang | 2018-02-20 |
| 9827226 | Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones | Bo Ren, Hexiang Wang | 2017-11-28 |
| 9670231 | Fused tricyclic amide compounds as multiple kinase inhibitors | Gouliang Zhang | 2017-06-06 |
| 9670203 | Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors | Guoliang Zhang | 2017-06-06 |
| 9617273 | Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors | Bo Ren, Hexiang Wang | 2017-04-11 |
| 9393232 | Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones | Bo Ren, Hexiang Wang | 2016-07-19 |
| 9328111 | Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors | Bo Ren, Hexiang Wang | 2016-05-03 |